Tech Center 1600 • Art Units: 1611 1614 1628
This examiner grants 26% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19191890 | LOW-SORBING GLYBURIDE FORMULATION AND METHODS | Final Rejection | REMEDY PHARMACEUTICALS, INC. |
| 17633973 | ENZYME INHIBITORS | Non-Final OA | KALVISTA PHARMACEUTICALS LIMITED |
| 17921540 | SOLID AND LIQUISOLID FORMULATIONS OF CORALLOPYRONIN A | Final Rejection | RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy